These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 3480904

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Risperidone versus pimozide in Tourette's disorder: a comparative double-blind parallel-group study.
    Bruggeman R, van der Linden C, Buitelaar JK, Gericke GS, Hawkridge SM, Temlett JA.
    J Clin Psychiatry; 2001 Jan; 62(1):50-6. PubMed ID: 11235929
    [Abstract] [Full Text] [Related]

  • 3. Relative efficacy of haloperidol and pimozide in children and adolescents with Tourette's disorder.
    Sallee FR, Nesbitt L, Jackson C, Sine L, Sethuraman G.
    Am J Psychiatry; 1997 Aug; 154(8):1057-62. PubMed ID: 9247389
    [Abstract] [Full Text] [Related]

  • 4. A comparison of pimozide and haloperidol in the treatment of Gilles de la Tourette's syndrome.
    Ross MS, Moldofsky H.
    Am J Psychiatry; 1978 May; 135(5):585-7. PubMed ID: 347954
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pimozide: use in Tourette's syndrome.
    Colvin CL, Tankanow RM.
    Drug Intell Clin Pharm; 1985 Jun; 19(6):421-4. PubMed ID: 3891283
    [Abstract] [Full Text] [Related]

  • 8. Short-term versus longer term pimozide therapy in Tourette's syndrome: a preliminary study.
    Neurology; 1999 Mar 10; 52(4):874-7. PubMed ID: 10078748
    [Abstract] [Full Text] [Related]

  • 9. Eye-blink rate in Tourette's syndrome.
    Karson CN, Kaufmann CA, Shapiro AK, Shapiro E.
    J Nerv Ment Dis; 1985 Sep 10; 173(9):566-9. PubMed ID: 3860628
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Controlled study of pimozide vs. placebo in Tourette's syndrome.
    Shapiro AK, Shapiro E.
    J Am Acad Child Psychiatry; 1984 Mar 10; 23(2):161-73. PubMed ID: 6371107
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Biochemical pharmacology of Gilles de la Tourette's syndrome.
    Messiha FS.
    Neurosci Biobehav Rev; 1988 Mar 10; 12(3-4):295-305. PubMed ID: 3067157
    [Abstract] [Full Text] [Related]

  • 16. Controlled study of haloperidol, pimozide and placebo for the treatment of Gilles de la Tourette's syndrome.
    Shapiro E, Shapiro AK, Fulop G, Hubbard M, Mandeli J, Nordlie J, Phillips RA.
    Arch Gen Psychiatry; 1989 Aug 10; 46(8):722-30. PubMed ID: 2665687
    [Abstract] [Full Text] [Related]

  • 17. Tourette's syndrome: update.
    Freeman RD, Connolly JE, Baird PA.
    Can Med Assoc J; 1984 Jun 15; 130(12):1554-7. PubMed ID: 6587930
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Fluvoxamine/pimozide treatment of concurrent Tourette's and obsessive-compulsive disorder.
    Delgado PL, Goodman WK, Price LH, Heninger GR, Charney DS.
    Br J Psychiatry; 1990 Nov 15; 157():762-5. PubMed ID: 2126219
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.